After being in and around the Los Angeles County start-up scene for the past years and observing the funding processes at some incubators, I am noticing that some VC's and incubators are selecting companies that do not appear to have much clinical validation work in the pre-series A stage.
I would like to know if there are investors and VC firms that have an interest in establishing some guidelines for pre-series A companies to achieve in early clinical validation work. If so, please contact me through this board. I am interested in holding a specific meeting on this topic in Orange County in June.